A: Rega marang dodolan Agilent Tech

Tandha merek Agilent Corp (A)

Agilent Technologies generates revenue through the supply of precision instruments and software for the pharmaceutical sector and laboratories. The smoothed P/S ratio for the company on the GURU.Markets daily chart reflects current dynamics, with the current value standing at 6.60. Moderate electronics outsourcing combined with in-house R&D minimizes risks, while strategic continuity following the CEO transition sustains steady investor optimism.

A (Agilent Corp) riwayat Kapitalisasi marang pendapatan saka 04.07.2022 nganti 13.11.2026

Agilent Tech (A) - rincian metrik lan laporan keuangan

- rega saiki lan proyeksi nilai saham:
Analisis umum perusahaan:A - agilent.com
Produk dadi Agilent Technologies, Inc.

Agilent Technologies' leadership in environmental sustainability and the transition to renewable energy create long-term value, which the market assesses via the price-to-sales ratio. By analyzing the fundamental P/S, an investor determines how many dollars of business value are attributed to each unit of revenue, allowing for an assessment of the premium paid for "green" technologies and the determination of the fair cost of capital.

Perusahaan pesaing

Rasio rega marang pendapatan DGX (questdiagnostics.com)|Multiplikator P/S ILMN (Illumina)|Exact Sciences Corp (EXAS) - Rega marang dodolan|RVTY - Rasio rega marang pendapatan|BIO (Bio-Rad Corp) - Rasio kapitalisasi marang pendapatan|NNNN (Anbio Biotechnology) - Kapitalisasi marang pendapatan|SHC: Kapitalisasi marang volume dodolan|Kapitalisasi marang pendapatan QDEL|OPK: Rasio kapitalisasi pasar marang pendapatan|Kapitalisasi marang pendapatan CDNA (CareDx Corp)|Kapitalisasi marang volume dodolan MRVI|Multiplikator P/S FLGT (Fulgent Genetics, Inc.)|fluidigm.com (LAB) - Rega marang dodolan|Cytek Biosciences - Multiplikator P/S|OraSure Technologies, Inc. (OSUR) - Kapitalisasi marang pendapatan|XGN: Multiplikator P/S|MDxHealth, Inc. - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Lucid Diagnostics Inc.|Rasio kapitalisasi marang pendapatan PRE (Prenetics Global Ltd)|Rasio rega marang pendapatan Insight Molecular Diagnostics (IMDX)|TRIB - Rega marang dodolan|Rasio rega marang pendapatan ProPhase PRPH|Ainos Corporation - Rasio rega marang pendapatan|CODX - Rasio rega marang pendapatan|Rega marang dodolan heartsciences.com|BMRA: Multiplikator P/S|Multiplikator rega marang pendapatan Cardio Diagnostics Holdings CDIO|ONCO (Onconetix Corp) - Multiplikator P/S|Virax Biolabs Corp (VRAX) - Koefisien rega marang pendapatan|Multiplikator P/S BJDX|AWH - Rega marang dodolan|Rasio rega marang pendapatan Accelerate Diagnostics, Inc. AXDX|Koefisien rega marang pendapatan Centogene N.V. (CNTG)|Enzo - Multiplikator P/S|FRES - Multiplikator P/S|gtglabs.com (GENE) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan 23andme.com|PMD (Psychemedics Corporation) - Multiplikator P/S